Risultati per: FANS e Rischio Cardiovascolare (Rischio CV)

Istituto Analisi delle politiche pubbliche, 9 su 10 sono insoddisfatti

Cresce del 50% il pericolo per il collo dell’utero

Allerta a Cagliari e Campobasso in arancione oggi e domani

Ricerca dell’Irccs Neuromed di Pozzilli

Infettate oltre 400 specie di uccelli e molti mammiferi

Pediatra: attenzione a cibi mal conservati, sabbia e piscinette

Verso livello record nel 2023, anche per riscaldamento globale

Morabito: ‘Fino a 5mila infortuni l’anno per estremi termici’

I consigli del ginecologo

Introduction
Prevention of cardiovascular disease (CVD) is of key importance in reducing morbidity, disability and mortality worldwide. Observational studies suggest that digital health interventions can be an effective strategy to reduce cardiovascular (CV) risk. However, evidence from large randomised clinical trials is lacking.

Methods and analysis
The CV-PREVITAL study is a multicentre, prospective, randomised, controlled, open-label interventional trial designed to compare the effectiveness of an educational and motivational mobile health (mHealth) intervention versus usual care in reducing CV risk. The intervention aims at improving diet, physical activity, sleep quality, psycho-behavioural aspects, as well as promoting smoking cessation and adherence to pharmacological treatment for CV risk factors. The trial aims to enrol approximately 80 000 subjects without overt CVDs referring to general practitioners’ offices, community pharmacies or clinics of Scientific Institute for Research, Hospitalization and Health Care (Italian acronym IRCCS) affiliated with the Italian Cardiology Network. All participants are evaluated at baseline and after 12 months to assess the effectiveness of the intervention on short-term endpoints, namely improvement in CV risk score and reduction of major CV risk factors. Beyond the funded life of the study, a long-term (7 years) follow-up is also planned to assess the effectiveness of the intervention on the incidence of major adverse CV events. A series of ancillary studies designed to evaluate the effect of the mHealth intervention on additional risk biomarkers are also performed.

Ethics and dissemination
This study received ethics approval from the ethics committee of the coordinating centre (Monzino Cardiology Center; R1256/20-CCM 1319) and from all other relevant IRBs and ethics committees. Findings are disseminated through scientific meetings and peer-reviewed journals and via social media. Partners are informed about the study’s course and findings through regular meetings.

Trial registration number
NCT05339841.

Medicinali assunti da 20 milioni di persone l’anno

Dai neonatologi i consigli per prevenire la disidratazione

Dai neonatologi i consigli per prevenire la disidratazione

Dai neonatologi i consigli per prevenire la disidratazione